Blood transfusion in the care of patients with visceral leishmaniasis: a review of practices in therapeutic efficacy studies
Open Access
- 1 May 2024
- journal article
- review article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 118 (8) , 481-490
Abstract
Blood transfusion remains an important aspect of patient management in visceral leishmaniasis (VL). However, transfusion triggers considered are poorly understood. This review summarises the transfusion practices adopted in VL efficacy studies using the Infectious Diseases Data Observatory VL clinical trials library. Of the 160 studies (1980–2021) indexed in the IDDO VL library, description of blood transfusion was presented in 16 (10.0%) (n=3459 patients) studies. Transfusion was initiated solely based on haemoglobin (Hb) measurement in nine studies, combining Hb measurement with an additional condition (epistaxis/poor health/clinical instability) in three studies and the criteria was not mentioned in four studies. The Hb threshold range for triggering transfusion was 3–8 g/dL. The number of patients receiving transfusion was explicitly reported in 10 studies (2421 patients enrolled, 217 underwent transfusion). The median proportion of patients who received transfusion in a study was 8.0% (Interquartile range: 4.7% to 47.2%; range: 0–100%; n=10 studies). Of the 217 patients requiring transfusion, 58 occurred before VL treatment initiation, 46 during the treatment/follow-up phase and the time was not mentioned in 113. This review describes the variation in clinical practice and is an important initial step in policy/guideline development, where both the patient's Hb concentration and clinical status must be considered.Keywords
All Related Versions
Funding Information
- Wellcome Trust (208378/Z/17/Z)
This publication has 39 references indexed in Scilit:
- Prevalence, severity, and pathogeneses of anemia in visceral leishmaniasisParasitology Research, 2016
- Which carries the biggest risk: Anaemia or blood transfusion?Transfusion Clinique et Biologique, 2015
- Leishmaniasis2014
- Hematologic Changes in Visceral Leishmaniasis/Kala AzarIndian Journal of Hematology and Blood Transfusion, 2010
- Maternal and perinatal outcomes of visceral leishmaniasis (kala‐azar) treated with sodium stibogluconate in eastern SudanInternational Journal of Gynecology & Obstetrics, 2009
- Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 casesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Efficacy of amphotericin B in multi-drug resistant kala-azar in children in first decade of lifeIndian Journal of Pediatrics, 1993
- Effect of blood transfusion on survival among children in a Kenyan hospitalThe Lancet, 1992
- Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis)Transactions of the Royal Society of Tropical Medicine and Hygiene, 1984
- A review of kala-azar in Malta from 1947 to 1962Transactions of the Royal Society of Tropical Medicine and Hygiene, 1964